John Peterson

Stock Analyst at Piper Sandler

(0.04)
# 4,170
Out of 4,761 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by John Peterson

Myriad Genetics
Jan 30, 2025
Maintains: Neutral
Price Target: $24$14
Current: $14.18
Upside: -1.27%